← Leaderboards
Abhishek Jain
Texas Engineering Experiment Station
$1,943,723
Attributed
$3,826,876
Total exposure
3
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $732.3K · FY2018–25$1M$750K$500K$250K$0
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$3,826,876 · 3
By mechanism
R01$2,824,730 · 1
R21$1,002,146 · 2
Top collaborators
- John H Connor4 shared
- John P Cooke4 shared
Most similar at Texas Engineering Experiment Station
Same institution · by research overlap
- Arum Han$8,262,649
- Thomas K Wood$2,025,512
- Thomas R Ioerger$2,713,607
- Kristen C. Maitland$1,480,636
- Jun Kameoka$198,107
Others in their field
Other Emerging Leaders on “Technology”
- Sonia M Thomas · Research Triangle Institute$700,865,642
- Tracy L Nolen · Research Triangle Institute$474,487,152
- Leonard Freedman · Leidos Biomedical Research, Inc.$436,612,396
- Valerie Koch · University Corporation For Atmospheric Res$252,793,840
- Joel A Lipkin · Four Points Technology, Llc$178,737,225
- Lisa Garcia Bedolla · University Of California-Berkeley$175,927,128
Research focus
TechnologyBlood VesselsDesignBloodOrgan On A ChipPhysiologicalEndotheliumCellsComplexInnovationThrombosisPharmaceutical PreparationsStrokeHemodynamicsOrganDevicesEndothelial CellsCytokineClinical ResearchPlayAutomobile DrivingImmune ResponseAmericanApoptosis
Grant awards (8)
Engineering Oral Tumor Microcirculation: Blood and lymphatic capillary network-enabled Human Oral Tumor Microenvironment Chips for Preclinical Research$421,625
R21 · FY2025 · DE · contact PI
Determinants of COVID19-induced venous thrombosis and targeted therapy assessed with bioengineered vein-chip$705,488
R01 · FY2024 · HL
Determinants of COVID19-induced venous thrombosis and targeted therapy assessed with bioengineered vein-chip$732,287
R01 · FY2023 · HL
Determinants of COVID19-induced venous thrombosis and targeted therapy assessed with bioengineered vein-chip$665,322
R01 · FY2022 · HL
Determinants of COVID19-induced venous thrombosis and targeted therapy assessed with bioengineered vein-chip$721,633
R01 · FY2021 · HL
An artery-on-a-chip system containing blood outgrowth endothelium as a model of vaso-occlusion and drug testing in sickle cell disease$175,087
R21 · FY2020 · EB · contact PI
An artery-on-a-chip system containing blood outgrowth endothelium as a model of vaso-occlusion and drug testing in sickle cell disease$176,598
R21 · FY2019 · EB · contact PI
An artery-on-a-chip system containing blood outgrowth endothelium as a model of vaso-occlusion and drug testing in sickle cell disease$228,836
R21 · FY2018 · EB · contact PI